Pakistan Successfully Performs First-Ever CAR T-Cell Therapy
Rawalpindi — Pakistan has achieved a major milestone in medical science by successfully performing the country's first CAR T-cell therapy, an advanced form of cancer treatment. With this achievement, Pakistan joins the group of countries capable of offering this cutting-edge cellular immunotherapy.
The procedure was carried out at the Armed Forces Bone Marrow Transplant Centre (AFBMT&C), where specialists from the Army Medical Corps successfully developed and delivered the treatment after years of research and preparation. According to the hospital, the 21-year-old patient who received the therapy has recovered and been discharged.
A Major Achievement After Years of Research
The breakthrough highlights Pakistan's growing capacity to provide highly specialized treatments for complex diseases within the country.
- How CAR T-Cell Therapy Works: The treatment involves collecting a patient's own T-cells, genetically modifying them in a laboratory to recognize and attack cancer cells, and then infusing them back into the patient's body.
- Patient's Journey: The 21-year-old patient and family underwent the pioneering treatment with the support of the medical team.
- International Standards: The successful procedure reflects the advancement of Pakistan's expertise in cellular therapy and cancer research.nt
Strengthening Pakistan's Medical Self-Reliance
The achievement is regarded as an important step toward expanding advanced cancer care in Pakistan. The Army Medical Corps and the Armed Forces Bone Marrow Transplant Centre are expected to play a significant role in the country's future research and treatment of blood cancers and other complex diseases.
Future Benefits
- Greater Accessibility: Advanced cancer treatment may become more accessible within Pakistan, reducing the need for patients to seek treatment abroad.
- Medical Self-Sufficiency: The development strengthens Pakistan's capability to treat diseases such as leukemia and other complex cancers domestically.
- Research Opportunities: The milestone is expected to encourage further research in biotechnology, immunotherapy, and genetic engineering by Pakistani scientists and medical professionals.
The successful recovery and discharge of the first patient marks a significant step forward for Pakistan's healthcare and medical research sector.